ArticleAnnals of surgical oncology2026

ASO Author Reflections: It is Time to Define an Optimal Duration of Neoadjuvant Treatment in Patients with Pancreatic Ductal Adenocarcinoma.

Shahin Hajibandeh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.